Spiegelmer Inhibition of CCL2/MCP-1 Ameliorates Lupus Nephritis in MRL-(Fas)lpr Mice-Reference-Cited by-同舟云学术

Spiegelmer Inhibition of CCL2/MCP-1 Ameliorates Lupus Nephritis in MRL-(Fas)lpr Mice

Published:2007-07-11 Issue:8 Volume:18 Page:2350-2358
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

Kulkarni Onkar,Pawar Rahul D.,Purschke Werner,Eulberg Dirk,Selve Norma,Buchner Klaus,Ninichuk Volha,Segerer Stephan,Vielhauer Volker,Klussmann Sven,Anders Hans-Joachim

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference30 articles.

1. Immune Therapy for Autoimmune Diseases

2. Chemokines and leukocyte traffic

3. Immune cell migration in inflammation: present and future therapeutic targets

4. Chemokines and disease

5. Chemokine Receptor Ccr2 Deficiency Reduces Renal Disease and Prolongs Survival in MRL/lpr Lupus-Prone Mice

Cited by 163 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Animal models of systemic lupus erythematosus (SLE);Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Clinical significance of serum soluble scavenger receptor CD163 in patients with lupus nephritis;Lupus;2024-08-22

3. The CCL2–CCR2 axis determines whether glomerular endocapillary hypercellularity or wire‐loop lesions develop through glomerular macrophage and neutrophil infiltration in lupus nephritis;The Journal of Pathology;2024-07-26

4. Therapeutic Applications of Aptamers;International Journal of Molecular Sciences;2024-06-19

5. Development of Better Aptamers: Structured Library Approaches, Selection Methods, and Chemical Modifications;Angewandte Chemie;2024-02-16